Study of a Series of Patients Treated for Retrograde Cricopharyngeal Muscle Dysfunction Syndrome
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Retrospective description of the characteristics of a series of patients treated for dysphagia syndrome
研究概览
简要总结
R-CPD syndrome (Retrograde Cricopharyngeal Dysfunction syndrome) is an inability to burp.
It is a syndrome whose diagnosis is clinical, and for which there is effective treatment. Recently treated in the United States (first publication in 2019), this syndrome affects many patients in France and is currently unknown.
This study concerns a series of patients treated at the University Hospitals of Strasbourg for a syndrome of retrograde dysfunction of the cricopharyngeus muscle having been treated by injection of botulinum toxin into the cricopharyngeus muscle.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Major subject (≥18 years old)
- •Subject treated by injection of botulinum toxin into the cricopharyngeal muscle after having had a diagnosis of R-CPD in consultation between January 1, 2022 and December 31, 2022
- •Subject not opposing the reuse of their data for the purposes of this research.
排除标准
- •Subject having expressed opposition to participating in the study,
- •Subject under judicial protection
- •Subject under guardianship or curatorship
结局指标
主要结局
Retrospective description of the characteristics of a series of patients treated for dysphagia syndrome
时间窗: Through study completion, an average of 2 months
Retrospective study of medical files of patients treated in HUS between January 1, 2022 and December 31, 2022
次要结局
未报告次要终点